222 related articles for article (PubMed ID: 25236655)
1. Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics.
Vater A; Klussmann S
Drug Discov Today; 2015 Jan; 20(1):147-55. PubMed ID: 25236655
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical stability of NOX-E36, a 40mer L-RNA (Spiegelmer) for therapeutic applications.
Maasch C; Buchner K; Eulberg D; Vonhoff S; Klussmann S
Nucleic Acids Symp Ser (Oxf); 2008; (52):61-2. PubMed ID: 18776253
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2.
Oberthür D; Achenbach J; Gabdulkhakov A; Buchner K; Maasch C; Falke S; Rehders D; Klussmann S; Betzel C
Nat Commun; 2015 Apr; 6():6923. PubMed ID: 25901662
[TBL] [Abstract][Full Text] [Related]
4. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.
Menne J; Eulberg D; Beyer D; Baumann M; Saudek F; Valkusz Z; Więcek A; Haller H;
Nephrol Dial Transplant; 2017 Feb; 32(2):307-315. PubMed ID: 28186566
[TBL] [Abstract][Full Text] [Related]
5. Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.
Steurer M; Montillo M; Scarfò L; Mauro FR; Andel J; Wildner S; Trentin L; Janssens A; Burgstaller S; Frömming A; Dümmler T; Riecke K; Baumann M; Beyer D; Vauléon S; Ghia P; Foà R; Caligaris-Cappio F; Gobbi M
Haematologica; 2019 Oct; 104(10):2053-2060. PubMed ID: 31097627
[TBL] [Abstract][Full Text] [Related]
6. Spiegelmer Inhibition of MCP-1/CCR2--Potential as an Adjunct Immunosuppressive Therapy in Transplantation.
Kalnins A; Thomas MN; Andrassy M; Müller S; Wagner A; Pratschke S; Rentsch M; Klussmann S; Kauke T; Angele MK; Bazhin AV; Fischereder M; Werner J; Guba M; Andrassy J
Scand J Immunol; 2015 Aug; 82(2):102-9. PubMed ID: 25970072
[TBL] [Abstract][Full Text] [Related]
7. A mixed mirror-image DNA/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes.
Vater A; Sell S; Kaczmarek P; Maasch C; Buchner K; Pruszynska-Oszmalek E; Kolodziejski P; Purschke WG; Nowak KW; Strowski MZ; Klussmann S
J Biol Chem; 2013 Jul; 288(29):21136-21147. PubMed ID: 23744070
[TBL] [Abstract][Full Text] [Related]
8. Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade.
Zboralski D; Hoehlig K; Eulberg D; Frömming A; Vater A
Cancer Immunol Res; 2017 Nov; 5(11):950-956. PubMed ID: 28963140
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
[TBL] [Abstract][Full Text] [Related]
10. A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation.
Hoehlig K; Johnson KW; Pryazhnikov E; Maasch C; Clemens-Smith A; Purschke WG; Vauléon S; Buchner K; Jarosch F; Khiroug L; Vater A; Klussmann S
Br J Pharmacol; 2015 Jun; 172(12):3086-98. PubMed ID: 25659966
[TBL] [Abstract][Full Text] [Related]
11. Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.
Maasch C; Vater A; Buchner K; Purschke WG; Eulberg D; Vonhoff S; Klussmann S
J Biol Chem; 2010 Dec; 285(51):40012-8. PubMed ID: 20961861
[TBL] [Abstract][Full Text] [Related]
12. Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects.
Boyce M; Warrington S; Cortezi B; Zöllner S; Vauléon S; Swinkels DW; Summo L; Schwoebel F; Riecke K
Br J Pharmacol; 2016 May; 173(10):1580-8. PubMed ID: 26773325
[TBL] [Abstract][Full Text] [Related]
13. RNA aptamers and spiegelmers: synthesis, purification, and post-synthetic PEG conjugation.
Hoffmann S; Hoos J; Klussmann S; Vonhoff S
Curr Protoc Nucleic Acid Chem; 2011 Sep; Chapter 4():Unit 4.46.1-30. PubMed ID: 21901672
[TBL] [Abstract][Full Text] [Related]
14. GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism.
Leva S; Lichte A; Burmeister J; Muhn P; Jahnke B; Fesser D; Erfurth J; Burgstaller P; Klussmann S
Chem Biol; 2002 Mar; 9(3):351-9. PubMed ID: 11927260
[TBL] [Abstract][Full Text] [Related]
15. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX.
Vater A; Jarosch F; Buchner K; Klussmann S
Nucleic Acids Res; 2003 Nov; 31(21):e130. PubMed ID: 14576330
[TBL] [Abstract][Full Text] [Related]
16. CXCL12/SDF-1-Dependent Retinal Migration of Endogenous Bone Marrow-Derived Stem Cells Improves Visual Function after Pharmacologically Induced Retinal Degeneration.
Enzmann V; Lecaudé S; Kruschinski A; Vater A
Stem Cell Rev Rep; 2017 Apr; 13(2):278-286. PubMed ID: 27924617
[TBL] [Abstract][Full Text] [Related]
17. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, pharmacodynamics and safety of aptamers.
Kovacevic KD; Gilbert JC; Jilma B
Adv Drug Deliv Rev; 2018 Sep; 134():36-50. PubMed ID: 30321620
[TBL] [Abstract][Full Text] [Related]
19. Selection and Application of Aptamers and Intramers.
Avci-Adali M
Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
[TBL] [Abstract][Full Text] [Related]
20. Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.
Ludwig H; Weisel K; Petrucci MT; Leleu X; Cafro AM; Garderet L; Leitgeb C; Foa R; Greil R; Yakoub-Agha I; Zboralski D; Vauléon S; Dümmler T; Beyer D; Kruschinski A; Riecke K; Baumann M; Engelhardt M
Leukemia; 2017 Apr; 31(4):997-1000. PubMed ID: 28074071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
